{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:56:59Z","timestamp":1778158619277,"version":"3.51.4"},"reference-count":52,"publisher":"Academy of Managed Care Pharmacy","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMCP"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.18553\/jmcp.2016.22.11.1349","type":"journal-article","created":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T17:57:24Z","timestamp":1477504644000},"page":"1349-1361","source":"Crossref","is-referenced-by-count":31,"title":["Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia"],"prefix":"10.18553","volume":"22","author":[{"given":"Joanna P.","family":"MacEwan","sequence":"first","affiliation":[{"name":"Precision Health Economics, Los Angeles, California."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicia M.","family":"Forma","sequence":"additional","affiliation":[{"name":"Otsuka Pharmaceutical Development & Commercialization, Rockville, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Shafrin","sequence":"additional","affiliation":[{"name":"Precision Health Economics, Los Angeles, California."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ainslie","family":"Hatch","sequence":"additional","affiliation":[{"name":"Otsuka Pharmaceutical Development & Commercialization, Rockville, Maryland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darius N.","family":"Lakdawalla","sequence":"additional","affiliation":[{"name":"Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, California."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Lindenmayer","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, New York University, New York, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7818","reference":[{"key":"B1","volume-title":"Practice Guideline for the Treatment of Patients with Schizophrenia","author":"Lehman AF","year":"2004"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04221"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.168.1.49"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(97)00131-X"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200208000-00002"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.56.3.241"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2010.09010087"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.55.8.886"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0107"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.15m10278"},{"key":"B11","unstructured":"National Committee for Quality Assurance. Adherence to antipsychotic medications for people with schizophrenia. 2015. Available at: http:\/\/www. ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality\/2015-table-of-contents\/antipsychotic-medications. Accessed September 29, 2016."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e3182984c1f"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080633"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S59339"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31828568bc"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2011.02.005"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1037\/1082-989X.4.2.139"},{"key":"B18","unstructured":"Jacobson G, Casillas G, Damico A, Neuman T, Gold M. Medicare Advantage 2016 spotlight: enrollment market update. Kaiser Family Foundation. May 11, 2016. Available at: http:\/\/kff.org\/medicare\/issue-brief\/medicare-advantage-2016-spotlight-enrollment-market-update\/. Accessed September 29, 2016."},{"key":"B19","unstructured":"Health Insurance Portability and Accountability Act of 1996. Public Law 104-191. 1996. Available at: http:\/\/www.gpo.gov\/fdsys\/pkg\/PLAW-104publ191\/html\/PLAW-104publ191.htm. Accessed September 29, 2016."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1592\/phco.2005.25.9.1242"},{"key":"B21","unstructured":"CLOZARIL (clozapine) tablets, for oral use. Novartis Pharmaceuticals. Revised September 2015. Available at: http:\/\/clozaril.com\/wp-content\/ themes\/eyesite\/pi\/Clozaril-2015A507-10022015-Approved.pdf. Accessed September 28, 2016."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a007076"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-013-0074-z"},{"key":"B24","unstructured":"Nau DP. Proportion of days covered (PDC) as a preferred method of measuring medication adherence. Pharmacy Quality Alliance. 2012. Available at: http:\/\/www.pqaalliance.org\/images\/uploads\/files\/PQA%20PDC%20vs%20 %20MPR.pdf. Accessed September 28, 2016."},{"key":"B25","unstructured":"Centers for Medicare & Medicaid Services. Medicare 2016 Part C & D Star Ratings Technical Notes. Draft. August 5, 2015. Available at: https:\/\/www. cms.gov\/Medicare\/Prescription-Drug-Coverage\/PrescriptionDrugCovGenIn\/ Downloads\/2016-Technical-Notes-Preview-1-v2015_08_05.pdf. Accessed October 4, 2016."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000182534.19832.83"},{"issue":"1","key":"B27","volume":"12","author":"Berger A","year":"2012","journal-title":"BMC Psychiatr y"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291706008191"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2013.816310"},{"key":"B30","unstructured":"National Institute of Mental Health. Schizophrenia. Available at: http:\/\/www.nimh.nih.gov\/health\/statistics\/prevalence\/schizophrenia.shtml. Accessed September 29, 2016."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2012.01911.x"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2009.05.004"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(01)00261-4"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1176\/ps.2010.61.12.1239"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-2-6"},{"issue":"1","key":"B36","first-page":"269","volume":"4","author":"Jin J","year":"2008","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"B37","first-page":"31","volume":"160","author":"Caro JJ","year":"1999","journal-title":"Canadian Med Assoc J"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-013-0016-5"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.060815"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20479"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.1.61"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2009.00543.x"},{"issue":"7","key":"B43","first-page":"631","volume":"14","author":"Kamat SA","year":"2008","journal-title":"J Manag Care Pharm"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1097\/01.psy.0000237316.09601.88"},{"issue":"4","key":"B45","first-page":"386","volume":"24","author":"Chabannes J","year":"1997","journal-title":"L\u2019 Encephale"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.48.5.412"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2007.01.033"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.21.2810"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2005.03.002"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1378\/chest.109.3.814"},{"issue":"6","key":"B51","volume":"96","author":"Mullins CD","year":"2004","journal-title":"J Natl Med Assoc"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-006-0179-x"}],"container-title":["Journal of Managed Care & Specialty Pharmacy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T16:14:05Z","timestamp":1725466445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmcp.org\/doi\/10.18553\/jmcp.2016.22.11.1349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.18553\/jmcp.2016.22.11.1349"],"URL":"https:\/\/doi.org\/10.18553\/jmcp.2016.22.11.1349","relation":{},"ISSN":["2376-0540","2376-1032"],"issn-type":[{"value":"2376-0540","type":"print"},{"value":"2376-1032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}